Go Pro
→ A new income category is drawing serious money - here's why (From Investors Alley) (Ad)tc pixel
OTCMKTS:DGNOF

DIAGNOS Q3 2025 Earnings Report

DIAGNOS logo
$0.34 -0.01 (-1.97%)
As of 10:08 AM Eastern
ProfileEarnings History

DIAGNOS EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

DIAGNOS Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

DIAGNOS Announcement Details

Quarter
Q3 2025
Date
2/12/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

DIAGNOS Earnings Headlines

DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344835/0/en/diagnos-receives-saudi-fda-medical-device-license-for-cara-system-bringing-ai-assisted-retinal-image-analysis-to-saudi-arabia.html
DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333833/0/en/diagnos-receives-health-canada-medical-device-licence-for-cara-system-bringing-ai-assisted-retinal-image-analysis-to-canadian-optometrists.html
The 2026 beginners Guide to Gold IRAs
Gold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of Americans use Gold IRAs to diversify retirement savings amid rising national debt. The free 2026 Beginner's Guide to Gold IRAs covers top advantages, penalty free 401k rollovers, and simple steps to get started.tc pixel
September 4 at 1:00 AM  |  Goldco Direct, LLC (Ad)
Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307455/0/en/emerging-growth-research-releases-flash-report-on-diagnos-highlighting-regulatory-catalysts-and-commercialization-potential-for-cara-ai-platform.html
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
June 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/03/3306199/0/en/diagnos-to-present-at-the-emerging-growth-conference-on-june-10-2026.html
DIAGNOS Announces Amendment to Convertible Debentures
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294556/0/en/diagnos-announces-amendment-to-convertible-debentures.html
See More DIAGNOS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email.

About DIAGNOS

DIAGNOS (OTCMKTS:DGNOF) provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

View DIAGNOS Profile
Earnings Tools